Global Biologics Outsourcing Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 Biologics Outsourcing Market Overview

• 1.1 Product Overview and Scope of Biologics Outsourcing
• 1.2 Classification of Biologics Outsourcing by Types
  • 1.2.1 Global Biologics Outsourcing Revenue Comparison by Types (2017-2023)
  • 1.2.2 Global Biologics Outsourcing Revenue Market Share by Types in 2017
  • 1.2.3 Antibody
  • 1.2.4 Recombinant
  • 1.2.5 Protein
  • 1.2.6 Vaccines
  • 1.2.7 Others
• 1.3 Global Biologics Outsourcing Market by Application
  • 1.3.1 Global Biologics Outsourcing Market Size and Market Share Comparison by Applications (2013-2023)
  • 1.3.2 Vaccine & Therapeutics Development
  • 1.3.3 Blood & Blood Related Products Testing
  • 1.3.4 Cellular and Gene Therapy
  • 1.3.5 Other
• 1.4 Global Biologics Outsourcing Market by Regions
  • 1.4.1 Global Biologics Outsourcing Market Size (Million USD) Comparison by Regions (2013-2023)
  • 1.4.1 North America (USA, Canada and Mexico) Biologics Outsourcing Status and Prospect (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Outsourcing Status and Prospect (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Outsourcing Status and Prospect (2013-2023)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Biologics Outsourcing Status and Prospect (2013-2023)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Outsourcing Status and Prospect (2013-2023)
• 1.5 Global Market Size of Biologics Outsourcing (2013-2023)

2 Manufacturers Profiles

• 2.1 Boehringer Ingelheim
  • 2.1.1 Business Overview
  • 2.1.2 Biologics Outsourcing Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Boehringer Ingelheim Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.2 Catalent
  • 2.2.1 Business Overview
  • 2.2.2 Biologics Outsourcing Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Catalent Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.3 GenScript
  • 2.3.1 Business Overview
  • 2.3.2 Biologics Outsourcing Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 GenScript Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.4 Innovent Biologics
  • 2.4.1 Business Overview
  • 2.4.2 Biologics Outsourcing Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Innovent Biologics Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.5 Syngene
  • 2.5.1 Business Overview
  • 2.5.2 Biologics Outsourcing Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Syngene Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.6 Shanghai Medicilon
  • 2.6.1 Business Overview
  • 2.6.2 Biologics Outsourcing Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Shanghai Medicilon Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.7 GL Biochem Corporation
  • 2.7.1 Business Overview
  • 2.7.2 Biologics Outsourcing Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 GL Biochem Corporation Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.8 GVK Biosciences Private
  • 2.8.1 Business Overview
  • 2.8.2 Biologics Outsourcing Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 GVK Biosciences Private Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.9 Horizon Discovery Group
  • 2.9.1 Business Overview
  • 2.9.2 Biologics Outsourcing Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Horizon Discovery Group Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.10 Innovent Biologics
  • 2.10.1 Business Overview
  • 2.10.2 Biologics Outsourcing Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Innovent Biologics Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.11 Selexis
  • 2.11.1 Business Overview
  • 2.11.2 Biologics Outsourcing Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Selexis Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.12 Lonza
  • 2.12.1 Business Overview
  • 2.12.2 Biologics Outsourcing Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Lonza Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.13 Abzena
  • 2.13.1 Business Overview
  • 2.13.2 Biologics Outsourcing Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Abzena Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)
• 2.14 Adimab
  • 2.14.1 Business Overview
  • 2.14.2 Biologics Outsourcing Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Adimab Biologics Outsourcing Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biologics Outsourcing Market Competition, by Players

• 3.1 Global Biologics Outsourcing Revenue and Share by Players (2013-2018)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Biologics Outsourcing Players Market Share
  • 3.2.2 Top 10 Biologics Outsourcing Players Market Share
• 3.3 Market Competition Trend

4 Global Biologics Outsourcing Market Size by Regions

• 4.1 Global Biologics Outsourcing Revenue and Market Share by Regions
• 4.2 North America Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 4.3 Europe Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 4.4 Asia-Pacific Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 4.5 South America Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 4.6 Middle East and Africa Biologics Outsourcing Revenue and Growth Rate (2013-2018)

5 North America Biologics Outsourcing Revenue by Countries

• 5.1 North America Biologics Outsourcing Revenue by Countries (2013-2018)
• 5.2 USA Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 5.3 Canada Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 5.4 Mexico Biologics Outsourcing Revenue and Growth Rate (2013-2018)

6 Europe Biologics Outsourcing Revenue by Countries

• 6.1 Europe Biologics Outsourcing Revenue by Countries (2013-2018)
• 6.2 Germany Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 6.3 UK Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 6.4 France Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 6.5 Russia Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 6.6 Italy Biologics Outsourcing Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Biologics Outsourcing Revenue by Countries

• 7.1 Asia-Pacific Biologics Outsourcing Revenue by Countries (2013-2018)
• 7.2 China Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 7.3 Japan Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 7.4 Korea Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 7.5 India Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 7.6 Southeast Asia Biologics Outsourcing Revenue and Growth Rate (2013-2018)

8 South America Biologics Outsourcing Revenue by Countries

• 8.1 South America Biologics Outsourcing Revenue by Countries (2013-2018)
• 8.2 Brazil Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 8.3 Argentina Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 8.4 Colombia Biologics Outsourcing Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Biologics Outsourcing by Countries

• 9.1 Middle East and Africa Biologics Outsourcing Revenue by Countries (2013-2018)
• 9.2 Saudi Arabia Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 9.3 UAE Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 9.4 Egypt Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 9.5 Nigeria Biologics Outsourcing Revenue and Growth Rate (2013-2018)
• 9.6 South Africa Biologics Outsourcing Revenue and Growth Rate (2013-2018)

10 Global Biologics Outsourcing Market Segment by Type

• 10.1 Global Biologics Outsourcing Revenue and Market Share by Type (2013-2018)
• 10.2 Global Biologics Outsourcing Market Forecast by Type (2018-2023)
• 10.3 Antibody Revenue Growth Rate (2013-2023)
• 10.4 Recombinant Revenue Growth Rate (2013-2023)
• 10.5 Protein Revenue Growth Rate (2013-2023)
• 10.6 Vaccines Revenue Growth Rate (2013-2023)
• 10.7 Others Revenue Growth Rate (2013-2023)

11 Global Biologics Outsourcing Market Segment by Application

• 11.1 Global Biologics Outsourcing Revenue Market Share by Application (2013-2018)
• 11.2 Biologics Outsourcing Market Forecast by Application (2018-2023)
• 11.3 Vaccine & Therapeutics Development Revenue Growth (2013-2018)
• 11.4 Blood & Blood Related Products Testing Revenue Growth (2013-2018)
• 11.5 Cellular and Gene Therapy Revenue Growth (2013-2018)
• 11.6 Other Revenue Growth (2013-2018)

12 Global Biologics Outsourcing Market Size Forecast (2018-2023)

• 12.1 Global Biologics Outsourcing Market Size Forecast (2018-2023)
• 12.2 Global Biologics Outsourcing Market Forecast by Regions (2018-2023)
• 12.3 North America Biologics Outsourcing Revenue Market Forecast (2018-2023)
• 12.4 Europe Biologics Outsourcing Revenue Market Forecast (2018-2023)
• 12.5 Asia-Pacific Biologics Outsourcing Revenue Market Forecast (2018-2023)
• 12.6 South America Biologics Outsourcing Revenue Market Forecast (2018-2023)
• 12.7 Middle East and Africa Biologics Outsourcing Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology